MedPath

Comparison of effect of Dexmedetomidine when given as Intravenous route and intraperitoneal route in Laparoscopic cholecystectomy

Not Applicable
Conditions
Health Condition 1: R17- Unspecified jaundice
Registration Number
CTRI/2021/05/033582
Lead Sponsor
Veer Surendra Sai institute Of Medical Sciences And Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients posted laparoscopic cholecystectomy under general anaesthesia

2.Age 18-60 years

3.ASA grade I and II

Exclusion Criteria

1.Patients with history of allergy to any medication

2.BMI >30Kg/m2

3.Preoperative HR <45/min

4.Patients using antihypertensive drug like clonidine(a2 adrenergic agonist

5.Renal or hepatic insufficiency

6.Patients with bleeding disorders

7.Patients with psychiatric disorders

8.Surgical procedure converted to open cholecystectomy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
As compared to IV Dexmedetomedine IP Dexmeditimedine might have not inferior for a better post-operative analgesic effect in Laparoscopic Cholecystectomy under general anaesthesia. <br/ ><br> <br/ ><br>Timepoint: Upto 24 hours <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1.To observe the incidence of adverse effects <br/ ><br>2.To calculate the total dose of analgesiaTimepoint: Upto 24 hours
© Copyright 2025. All Rights Reserved by MedPath